These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20827180)

  • 1. Contrast-specific propensity scores for causal inference with multiple interventions.
    Han S; Goh J; Meng F; Leow MK; Rubin DB
    Stat Methods Med Res; 2024 May; 33(5):825-837. PubMed ID: 38499338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase 1 status is a major Janus-faced component of mild and moderate acute ischemic stroke and consequent disabilities.
    Brinholi FF; Michelin AP; Matsumoto AK; de O Semeão L; Almulla AF; Supasitthumrong T; Tunvirachaisakul C; Barbosa DS; Maes M
    Metab Brain Dis; 2023 Aug; 38(6):2115-2131. PubMed ID: 37204661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.
    Mackness M; Mackness B
    Gene; 2015 Aug; 567(1):12-21. PubMed ID: 25965560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice.
    Uehara Y; Ando S; Yahiro E; Oniki K; Ayaori M; Abe S; Kawachi E; Zhang B; Shioi S; Tanigawa H; Imaizumi S; Miura S; Saku K
    J Am Heart Assoc; 2013 May; 2(3):e000048. PubMed ID: 23709562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted benzamides containing azaspiro rings as upregulators of apolipoprotein A-I transcription.
    Du Y; Yang Y; Jiang W; Wang L; Jia XJ; Si SY; Chen XF; Hong B
    Molecules; 2012 Jun; 17(6):7379-86. PubMed ID: 22699570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer.
    Su F; Grijalva V; Navab K; Ganapathy E; Meriwether D; Imaizumi S; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Mol Cancer Ther; 2012 Jun; 11(6):1311-9. PubMed ID: 22416044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis: targeting endogenous apo A-I--a new approach for raising HDL.
    Shah PK
    Nat Rev Cardiol; 2011 Apr; 8(4):187-8. PubMed ID: 21364534
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL.
    Shah PK
    Curr Opin Cardiol; 2010 Nov; 25(6):603-8. PubMed ID: 20827180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?
    Rana JS; Boekholdt SM
    Curr Opin Cardiol; 2010 Nov; 25(6):622-6. PubMed ID: 20852414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
    Taylor AJ
    Am J Cardiol; 2008 Apr; 101(8A):36B-43B. PubMed ID: 18375240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.